plasmid DNA based PD-L1 gene therapy (enGene Inc)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameplasmid DNA based PD-L1 gene therapy (enGene Inc)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionProgrammed death-ligand 1 modulators
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsGraft vs Host DiseaseInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesenGene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesenGene Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A